NIH-funded research R01 grant

Understanding how PP2A phosphatase mutations cause diseases

Official title: Structural basis of PP2A phosphatase diseases

Funded at University of Wisconsin-Madison · NIH-10907816 · Data updated 2026-11-12

This study is looking at how a protein called PP2A works in diseases like cancer and brain disorders, to help find better ways to diagnose and treat people affected by these conditions.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Wisconsin-Madison
NIH-funded
Lab location1 site (Madison, United States)
Project startSeptember 1, 2023
Project endJune 30, 2027
Funding year2024
Award (this year)$361,963
NIH project number5R01GM145811-02
Project IDNIH-10907816 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include patients with specific types of cancer or neurological disorders associated with PP2A mutations.

Less likely to help

Patients without any known PP2A mutations or those with unrelated conditions may not benefit from this research.

What this research studies

This research investigates the role of Protein Phosphatase 2A (PP2A) in various diseases, particularly cancers and neurological disorders. By utilizing advanced techniques like cryo-electron microscopy and molecular dynamics simulations, the team aims to uncover how mutations in PP2A subunits affect its function and contribute to disease. The research involves analyzing the structures of both normal and mutated forms of PP2A to understand their dynamics and interactions with other proteins. This could lead to better diagnostic and therapeutic strategies for patients with these conditions.

Why it matters

Potential benefit: If successful, this research could lead to improved understanding and treatment options for patients suffering from cancers and neurological disorders linked to PP2A mutations.

How similar studies have gone: Previous research has shown promising results in understanding the role of PP2A in diseases, indicating that this approach could yield valuable insights.

Where this research is happening

  • University of Wisconsin-Madison
    Madison, United States
    Active

Researchers

  • Principal investigator: Xing, Yongna — University of Wisconsin-Madison
  • Study coordinator: Xing, Yongna

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.